Charles Trout
Internal Medicine · Albany, NYNPI 1215929344
Payments from drug & device makers
Across 347 payments — averaging $14.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$882
- AstraZeneca$500
- Merck$426
- Boehringer Ingelheim$398
- GSK$387
- AbbVie$362
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,148100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 67 | $882 |
| AstraZeneca | 20 | $500 |
| Merck | 32 | $426 |
| Boehringer Ingelheim | 28 | $398 |
| GSK | 27 | $387 |
| AbbVie(2 entities) | 31 | $362 |
| Pfizer | 16 | $269 |
| Johnson & Johnson | 14 | $243 |
| Novartis | 13 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $148 |
| E.r. Squibb & Sons, L.L.C. | 8 | $128 |
| Biohaven Pharmaceuticals, Inc. | 9 | $115 |
| Lilly USA, LLC | 8 | $109 |
| Sanofi-aventis U.S. LLC | 7 | $101 |
| Eisai Inc. | 4 | $92 |
| Amarin Pharma, Inc. | 6 | $87 |
| Amgen | 6 | $82 |
| Currax Pharmaceuticals LLC | 6 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $77 |
| Abbott | 4 | $76 |
| Bayer | 4 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Astellas Pharma US Inc | 3 | $50 |
| Sanofi Pasteur Inc. | 3 | $49 |
| Esperion Therapeutics, Inc. | 3 | $40 |
| Mannkind Corporation | 2 | $25 |
| Edwards Lifesciences | 1 | $18 |
| Medtronic | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Biogen | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$5,148 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Albany
- Scott BeegleAlbany$2.1M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.